1399 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333 +RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERS

Authors:
  • FPF. Poordad
    F. Poordad
  • ELE. Lawitz
    E. Lawitz
  • KKK.V. Kowdley
    K.V. Kowdley
  • GEG.T. Everson
    G.T. Everson
  • BFB. Freilich
    B. Freilich
  • DCD. Cohen
    D. Cohen
  • SSS. Siggelkow
    S. Siggelkow
  • MHM. Heckaman
    M. Heckaman
  • RMR. Menon
    R. Menon
  • TMT. Pilot- Matias
    T. Pilot- Matias
  • TPT. Podsadecki
    T. Podsadecki
  • BBB. Bernstein
    B. Bernstein
Publisher website
Google Scholar
Abstract
No abstract available